Further, NEDD4L was found to inhibit ULK1- and ASCT2-mediated mitophagy whereby suppressing adequate fuel supplementation via mitochondrial metabolism, leading to inducing cell death and inhibiting tumor growth in pancreatic cancer cells (Lee et al. 2020a). Here, SLC1A5 is linked to neoplasm.